66.5JPY
89.33 BJPY
820.21 BJPY
1.22 B
About TERUMO CORP
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Employees (FY)
30.21 K
Founded
1921
ISIN
JP3546800008
FIGI
BBG000BK09M8
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4543 is 2538.5 JPY — it has decreased by 1.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TERUMO CORP stocks are traded under the ticker 4543.
TERUMO CORP is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4543 stock is 2.45% volatile and has beta coefficient of 1.13. Check out the list of the most volatile stocks — is TERUMO CORP there?
One year price forecast for TERUMO CORP has a max estimate of 3550.0 JPY and a min estimate of 2450.0 JPY.
4543 earnings for the last quarter are 18.50 JPY per share, whereas the estimation was 15.82 JPY resulting in a 16.88% surprise. The estimated earnings for the next quarter are 19.77 JPY per share. See more details about TERUMO CORP earnings.
TERUMO CORP revenue for the last quarter amounts to 228.62 B JPY despite the estimated figure of 219.11 B JPY. In the next quarter revenue is expected to reach 227.48 B JPY.
Yes, you can track TERUMO CORP financials in yearly and quarterly reports right on TradingView.
4543 stock has fallen by 2.81% compared to the previous week, the month change is a 11.12% fall, over the last year TERUMO CORP has showed a 29.09% increase.
4543 net income for the last quarter is 29.81 B JPY, while the quarter before that showed 27.54 B JPY of net income which accounts for 8.22% change. Track more TERUMO CORP financial stats to get the full picture.
Today TERUMO CORP has the market capitalization of 3.81 T, it has decreased by 1.67% over the last week.
TERUMO CORP dividend yield was 1.12% in 2022, and payout ratio reached 33.61%. The year before the numbers were 0.91% and 28.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4543 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERUMO CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 30.21 K employees. See our rating of the largest employees — is TERUMO CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TERUMO CORP technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TERUMO CORP stock shows the buy signal. See more of TERUMO CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TERUMO CORP future price: according to them, 4543 price has a max estimate of 3550.00 JPY and a min estimate of 2450.00 JPY. Read a more detailed TERUMO CORP forecast: see what analysts think of TERUMO CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TERUMO CORP EBITDA is 200.77 B JPY, and current EBITDA margin is 22.87%. See more stats in TERUMO CORP financial statements.